FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2654-2666 December 22, 2005 Number 25 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Parmiani, G. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown.

Methods We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors).

Results Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor–node–metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of immune cells and increased levels of messenger RNA (mRNA) for products of type 1 helper effector T cells (CD8, T-BET [T-box transcription factor 21], interferon regulatory factor 1, interferon-, granulysin, and granzyme B) but not increased levels of inflammatory mediators or immunosuppressive molecules. The two types of tumors had significant differences in the levels of expression of 65 combinations of T-cell markers, and hierarchical clustering showed that markers of T-cell migration, activation, and differentiation were increased in tumors without signs of early metastatic invasion. The latter type of tumors also had increased numbers of CD8+ T cells, ranging from early memory (CD45RO+CCR7–CD28+CD27+) to effector memory (CD45RO+CCR7–CD28–CD27–) T cells. The presence of high levels of infiltrating memory CD45RO+ cells, evaluated immunohistochemically, correlated with the absence of signs of early metastatic invasion, a less advanced pathological stage, and increased survival.

Conclusions Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.

Source Information

From INSERM Unité 255, René Descartes Faculté de Médecine, Assistance Publique–Hôpitaux de Paris, Cordeliers Biomedical Research Center, University Paris 6, Paris (F.P., M.C., A.C., A.K., M.N., W.-H.F., J.G.); the Laboratory of Immunology (F.P., W.-H.F.) and the Departments of General and Digestive Surgery (A.B., P.-H.C.) and Pathology (D.D., T.M., P.B.), Georges Pompidou European Hospital, Paris; and the Institute for Genomics and Bioinformatics, Graz University of Technology, Graz, Austria (F.S.-C., R.M., B.M., Z.T.).

Drs. Pagès and Berger contributed equally to the article.

Address reprint requests to Dr. Galon at INSERM U255, 15 rue de l'Ecole de Médecine, Centre de Recherches Biomédicales des Cordeliers, 75006 Paris, France, or at jerome.galon{at}u255.bhdc.jussieu.fr.

Full Text of this Article

Related Letters:

Immune Cells in Colorectal Cancer
Wolf D., Marth C., Wolf A. M., Pagès F., Galon J.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1531-1532, Apr 6, 2006. Correspondence

This article has been cited by other articles:

• Chaput, N, Louafi, S, Bardier, A, Charlotte, F, Vaillant, J-C, Menegaux, F, Rosenzwajg, M, Lemoine, F, Klatzmann, D, Taieb, J (2009). Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58: 520-529 [Abstract] [Full Text]  
• Camus, M., Tosolini, M., Mlecnik, B., Pages, F., Kirilovsky, A., Berger, A., Costes, A., Bindea, G., Charoentong, P., Bruneval, P., Trajanoski, Z., Fridman, W.-H., Galon, J. (2009). Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence. Cancer Res. 69: 2685-2693 [Abstract] [Full Text]  
• Jursik, C., Prchal, M., Grillari-Voglauer, R., Drbal, K., Fuertbauer, E., Jungfer, H., Albert, W. H., Steinhuber, E., Hemetsberger, T., Grillari, J., Stockinger, H., Katinger, H. (2009). Large-Scale Production and Characterization of Novel CD4+ Cytotoxic T Cells with Broad Tumor Specificity for Immunotherapy. Mol Cancer Res 7: 339-353 [Abstract] [Full Text]  
• Ruby, C. E., Weinberg, A. D. (2009). OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age. J. Immunol. 182: 1481-1489 [Abstract] [Full Text]  
• Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., Iacopetta, B. (2009). Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer. JCO 27: 186-192 [Abstract] [Full Text]  
• Ribas, A., Comin-Anduix, B., Economou, J. S., Donahue, T. R., de la Rocha, P., Morris, L. F., Jalil, J., Dissette, V. B., Shintaku, I. P., Glaspy, J. A., Gomez-Navarro, J., Cochran, A. J. (2009). Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade. Clin. Cancer Res. 15: 390-399 [Abstract] [Full Text]  
• Brody, J. D., Goldstein, M. J., Czerwinski, D. K., Levy, R. (2009). Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors. Blood 113: 85-94 [Abstract] [Full Text]  
• Aloulou, N., Bastuji-Garin, S., Le Gouvello, S., Abolhassani, M., Chaumette, M. T., Charachon, A., Leroy, K., Sobhani, I. (2008). Involvement of the Leptin Receptor in the Immune Response in Intestinal Cancer. Cancer Res. 68: 9413-9422 [Abstract] [Full Text]  
• Abolhassani, M., Aloulou, N., Chaumette, M. T., Aparicio, T., Martin-Garcia, N., Mansour, H., Le Gouvello, S., Delchier, J. C., Sobhani, I. (2008). Leptin Receptor-Related Immune Response in Colorectal Tumors: The Role of Colonocytes and Interleukin-8. Cancer Res. 68: 9423-9432 [Abstract] [Full Text]  
• Umansky, V., Abschuetz, O., Osen, W., Ramacher, M., Zhao, F., Kato, M., Schadendorf, D. (2008). Melanoma-Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice without Macroscopic Tumors. Cancer Res. 68: 9451-9458 [Abstract] [Full Text]  
• Maccalli, C., Di Cristanziano, V., Fodale, V., Corsi, D., D'Agostino, G., Petrangeli, V., Laurenti, L., Guida, S., Mazzocchi, A., Arienti, F., Perrone, M. P., Castelli, C., Rivoltini, L., Zagonel, V., Tartaglia, M., Parmiani, G., Belardelli, F. (2008). Induction of Both CD8+ and CD4+ T-Cell-Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1. Clin. Cancer Res. 14: 7292-7303 [Abstract] [Full Text]  
• Marchesi, F., Piemonti, L., Fedele, G., Destro, A., Roncalli, M., Albarello, L., Doglioni, C., Anselmo, A., Doni, A., Bianchi, P., Laghi, L., Malesci, A., Cervo, L., Malosio, M., Reni, M., Zerbi, A., Di Carlo, V., Mantovani, A., Allavena, P. (2008). The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma. Cancer Res. 68: 9060-9069 [Abstract] [Full Text]  
• Pages, F., Galon, J., Fridman, W. H. (2008). The essential role of the in situ immune reaction in human colorectal cancer. J. Leukoc. Biol. 84: 981-987 [Abstract] [Full Text]  
• Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., Lebecque, S., Fridman, W.-H., Cadranel, J. (2008). Long-Term Survival for Patients With Non-Small-Cell Lung Cancer With Intratumoral Lymphoid Structures. JCO 26: 4410-4417 [Abstract] [Full Text]  
• Janson, P. C. J., Marits, P., Thorn, M., Ohlsson, R., Winqvist, O. (2008). CpG Methylation of the IFNG Gene as a Mechanism to Induce Immunosupression in Tumor-Infiltrating Lymphocytes. J. Immunol. 181: 2878-2886 [Abstract] [Full Text]  
• Menard, C., Ghiringhelli, F., Roux, S., Chaput, N., Mateus, C., Grohmann, U., Caillat-Zucman, S., Zitvogel, L., Robert, C. (2008). CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma: Surrogate Marker of Efficacy of Tremelimumab?. Clin. Cancer Res. 14: 5242-5249 [Abstract] [Full Text]  
• Wagner, P., Koch, M., Nummer, D., Palm, S., Galindo, L., Autenrieth, D., Schmitz-Winnenthal, F. H., Schirrmacher, V., Buchler, M. W., Beckhove, P., Weitz, J. (2008). Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal Cancer. Ann. Surg. Oncol. 15: 2310-2317 [Abstract] [Full Text]  
• Dulphy, N., Haas, P., Busson, M., Belhadj, S., Peffault de Latour, R., Robin, M., Carmagnat, M., Loiseau, P., Tamouza, R., Scieux, C., Rabian, C., Di Santo, J. P., Charron, D., Janin, A., Socie, G., Toubert, A. (2008). An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation. J. Immunol. 181: 2227-2237 [Abstract] [Full Text]  
• Loddenkemper, C., Nagorsen, D., Zeitz, M. (2008). Foxp3 and microsatellite stability phenotype in colorectal cancer. Gut 57: 725-726 [Full Text]  
• Le Gouvello, S, Bastuji-Garin, S, Aloulou, N, Mansour, H, Chaumette, M-T, Berrehar, F, Seikour, A, Charachon, A, Karoui, M, Leroy, K, Farcet, J-P, Sobhani, I (2008). High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57: 772-779 [Abstract] [Full Text]  
• Han, L. Y., Fletcher, M. S., Urbauer, D. L., Mueller, P., Landen, C. N., Kamat, A. A., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Deavers, M. T., De Geest, K., Gershenson, D. M., Lutgendorf, S. K., Ferrone, S., Sood, A. K. (2008). HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma. Clin. Cancer Res. 14: 3372-3379 [Abstract] [Full Text]  
• Dahl, K., Karlsson, M., Marits, P., Hoffstedt, A., Winqvist, O., Thorn, M. (2008). Metinel Node--The First Lymph Node Draining a Metastasis--Contains Tumor-Reactive Lymphocytes. Ann. Surg. Oncol. 15: 1454-1463 [Abstract] [Full Text]  
• Ladoire, S., Arnould, L., Apetoh, L., Coudert, B., Martin, F., Chauffert, B., Fumoleau, P., Ghiringhelli, F. (2008). Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells. Clin. Cancer Res. 14: 2413-2420 [Abstract] [Full Text]  
• Worschech, A., Kmieciak, M., Knutson, K. L., Bear, H. D., Szalay, A. A., Wang, E., Marincola, F. M., Manjili, M. H. (2008). Signatures Associated with Rejection or Recurrence in HER-2/neu-Positive Mammary Tumors. Cancer Res. 68: 2436-2446 [Abstract] [Full Text]  
• Morris, M., Platell, C., Iacopetta, B. (2008). Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy. Clin. Cancer Res. 14: 1413-1417 [Abstract] [Full Text]  
• de Bruin, E. C., van de Velde, C. J.H., van Krieken, J. H. J.M., Marijnen, C. A.M., Medema, J. P. (2008). Epithelial Human Leukocyte Antigen-DR Expression Predicts Reduced Recurrence Rates and Prolonged Survival in Rectal Cancer Patients. Clin. Cancer Res. 14: 1073-1079 [Abstract] [Full Text]  
• Montes, C. L., Chapoval, A. I., Nelson, J., Orhue, V., Zhang, X., Schulze, D. H., Strome, S. E., Gastman, B. R. (2008). Tumor-Induced Senescent T Cells with Suppressor Function: A Potential Form of Tumor Immune Evasion. Cancer Res. 68: 870-879 [Abstract] [Full Text]  
• Stearman, R. S., Dwyer-Nield, L., Grady, M. C., Malkinson, A. M., Geraci, M. W. (2008). A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment. Cancer Res. 68: 34-43 [Abstract] [Full Text]  
• Alexe, G., Dalgin, G. S., Scanfeld, D., Tamayo, P., Mesirov, J. P., DeLisi, C., Harris, L., Barnard, N., Martel, M., Levine, A. J., Ganesan, S., Bhanot, G. (2007). High Expression of Lymphocyte-Associated Genes in Node-Negative HER2+ Breast Cancers Correlates with Lower Recurrence Rates. Cancer Res. 67: 10669-10676 [Abstract] [Full Text]  
• Chang, K.-C., Huang, G.-C., Jones, D., Lin, Y.-H. (2007). Distribution Patterns of Dendritic Cells and T Cells in Diffuse Large B-Cell Lymphomas Correlate with Prognoses. Clin. Cancer Res. 13: 6666-6672 [Abstract] [Full Text]  
• Wong, S. L., Ji, H., Hollenbeck, B. K., Morris, A. M., Baser, O., Birkmeyer, J. D. (2007). Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer. JAMA 298: 2149-2154 [Abstract] [Full Text]  
• Atreya, I., Schimanski, C. C, Becker, C., Wirtz, S., Dornhoff, H., Schnurer, E., Berger, M. R, Galle, P. R, Herr, W., Neurath, M. F (2007). The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut 56: 1572-1578 [Abstract] [Full Text]  
• Filaci, G., Fenoglio, D., Fravega, M., Ansaldo, G., Borgonovo, G., Traverso, P., Villaggio, B., Ferrera, A., Kunkl, A., Rizzi, M., Ferrera, F., Balestra, P., Ghio, M., Contini, P., Setti, M., Olive, D., Azzarone, B., Carmignani, G., Ravetti, J. L., Torre, G., Indiveri, F. (2007). CD8+CD28 T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers. J. Immunol. 179: 4323-4334 [Abstract] [Full Text]  
• Webster, W. S., Thompson, R. H., Harris, K. J., Frigola, X., Kuntz, S., Inman, B. A., Dong, H. (2007). Targeting Molecular and Cellular Inhibitory Mechanisms for Improvement of Antitumor Memory Responses Reactivated by Tumor Cell Vaccine. J. Immunol. 179: 2860-2869 [Abstract] [Full Text]  
• Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., Salerno, A., Eberl, M., Hayday, A. C. (2007). Targeting Human {gamma}{delta} T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer. Cancer Res. 67: 7450-7457 [Abstract] [Full Text]  
• Touitou, V., Daussy, C., Bodaghi, B., Camelo, S., de Kozak, Y., Lehoang, P., Naud, M.-C., Varin, A., Thillaye-Goldenberg, B., Merle-Beral, H., Fridman, W. H., Sautes-Fridman, C., Fisson, S. (2007). Impaired Th1/Tc1 Cytokine Production of Tumor-Infiltrating Lymphocytes in a Model of Primary Intraocular B-Cell Lymphoma. IOVS 48: 3223-3229 [Abstract] [Full Text]  
• Cesana, G. C., Romano, F., Piacentini, G., Scotti, M., Brenna, A., Bovo, G., Vaghi, M., Aletti, G., Caprotti, R., Kaufman, H., Uggeri, F. (2007). Low-dose Interleukin-2 Administered Pre-operatively to Patients with Gastric Cancer Activates Peripheral and Peritumoral Lymphocytes But Does Not Affect Prognosis. Ann. Surg. Oncol. 14: 1295-1304 [Abstract] [Full Text]  
• Zipin-Roitman, A., Meshel, T., Sagi-Assif, O., Shalmon, B., Avivi, C., Pfeffer, R. M., Witz, I. P., Ben-Baruch, A. (2007). CXCL10 Promotes Invasion-Related Properties in Human Colorectal Carcinoma Cells. Cancer Res. 67: 3396-3405 [Abstract] [Full Text]  
• Taylor, R. C., Patel, A., Panageas, K. S., Busam, K. J., Brady, M. S. (2007). Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma. JCO 25: 869-875 [Abstract] [Full Text]  
• Galon, J., Fridman, W.-H., Pages, F. (2007). The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel Perspective. Cancer Res. 67: 1883-1886 [Abstract] [Full Text]  
• Perrot, I., Blanchard, D., Freymond, N., Isaac, S., Guibert, B., Pacheco, Y., Lebecque, S. (2007). Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage. J. Immunol. 178: 2763-2769 [Abstract] [Full Text]  
• Ling, K.-L., Dulphy, N., Bahl, P., Salio, M., Maskell, K., Piris, J., Warren, B. F., George, B. D., Mortensen, N. J., Cerundolo, V. (2007). Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL. J. Immunol. 178: 2908-2915 [Abstract] [Full Text]  
• Lin, Y.-H., Friederichs, J., Black, M. A., Mages, J., Rosenberg, R., Guilford, P. J., Phillips, V., Thompson-Fawcett, M., Kasabov, N., Toro, T., Merrie, A. E., van Rij, A., Yoon, H.-S., McCall, J. L., Siewert, J. R., Holzmann, B., Reeve, A. E. (2007). Multiple Gene Expression Classifiers from Different Array Platforms Predict Poor Prognosis of Colorectal Cancer. Clin. Cancer Res. 13: 498-507 [Abstract] [Full Text]  
• Huang, L. P., Lyu, S.-C., Clayberger, C., Krensky, A. M. (2007). Granulysin-Mediated Tumor Rejection in Transgenic Mice. J. Immunol. 178: 77-84 [Abstract] [Full Text]  
• Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoue, F., Bruneval, P., Cugnenc, P.-H., Trajanoski, Z., Fridman, W.-H., Pages, F. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.. Science 313: 1960-1964 [Abstract] [Full Text]  
• Chaput, N., Flament, C., Viaud, S., Taieb, J., Roux, S., Spatz, A., Andre, F., LePecq, J.-B., Boussac, M., Garin, J., Amigorena, S., Thery, C., Zitvogel, L. (2006). Dendritic cell derived-exosomes: biology and clinical implementations. J. Leukoc. Biol. 80: 471-478 [Abstract] [Full Text]  
• Bini, E. J., Park, J., Francois, F. (2006). Use of Flexible Sigmoidoscopy to Screen for Colorectal Cancer in HIV-Infected Patients 50 Years of Age and Older.. Arch Intern Med 166: 1626-1631 [Abstract] [Full Text]  
• Johnson, P. M., Porter, G. A., Ricciardi, R., Baxter, N. N. (2006). Increasing Negative Lymph Node Count Is Independently Associated With Improved Long-Term Survival in Stage IIIB and IIIC Colon Cancer. JCO 24: 3570-3575 [Abstract] [Full Text]  
• Bui, J. D., Uppaluri, R., Hsieh, C.-S., Schreiber, R. D. (2006). Comparative Analysis of Regulatory and Effector T Cells in Progressively Growing versus Rejecting Tumors of Similar Origins.. Cancer Res. 66: 7301-7309 [Abstract] [Full Text]  
• Hegmans, J. P. J. J., Hemmes, A., Hammad, H., Boon, L., Hoogsteden, H. C., Lambrecht, B. N. (2006). Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Eur Respir J 27: 1086-1095 [Abstract] [Full Text]  
• Kaufman, H. L., Wolchok, J. D. (2006). Is Tumor Immunity the Same Thing As Autoimmunity? Implications for Cancer Immunotherapy. JCO 24: 2230-2232 [Full Text]  
• Wolf, D., Marth, C., Wolf, A. M., Pages, F., Galon, J. (2006). Immune Cells in Colorectal Cancer. NEJM 354: 1531-1532 [Full Text]  
• Abramson, J. S. (2006). T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.. The Oncologist 11: 384-392 [Abstract] [Full Text]  
• (2006). Inflammatory Response in Colorectal Cancer Is a Good Prognostic Sign. JWatch Gastroenterology 2006: 3-3 [Full Text]